Researchers and patient advocates from the Monell Chemical Senses Center, Smell and Taste Association of North America (STANA), and Thomas Jefferson University came together during the COVID-19 pandemic to incorporate patient ...
Jun 11, 2024
0
0
A team of Australia's leading health researchers has developed a new "dictionary" to better predict outcomes for people who have experienced a moderate-severe traumatic brain injury (TBI). The work is published in the Journal ...
Jun 11, 2024
0
0
As the immediate threat of COVID-19 subsides, investigating the virus's lasting impacts remains essential. A new study led by researchers at Emory AI.Health, published in Computers in Medicine and Biology, sheds light on ...
Jun 11, 2024
0
11
Benign prostatic hyperplasia, also called an enlarged prostate, is incredibly common, especially among men over 40. While it's not the same as prostate cancer, an enlarged prostate can cause significant quality of life issues.
Jun 11, 2024
0
0
Chronic lung diseases are often accelerated and exacerbated by polymicrobial infections. An international study team led by MedUni Vienna has identified two types of these so-called dysbioses in cystic fibrosis. They display ...
Jun 11, 2024
0
12
Mosquitoes have tested positive for West Nile virus in Sacramento County for the first time this year, officials said on June 10.
Jun 11, 2024
0
4
Cases of dengue and other mosquito-borne diseases are rising significantly in Europe as climate change creates warmer conditions that help invasive mosquitos spread, the EU's health agency warned on Tuesday.
Jun 11, 2024
0
0
In the United States, various minority racial and ethnic groups have reduced access to quality health care compared to their non-Hispanic white counterparts. Studies have shown that implicit biases among health care professionals ...
Jun 10, 2024
0
0
Brazil and Mexico may be affected by a much greater spread of dengue in the years to come, according to a new study from the University of Toronto's Temerty Faculty of Medicine.
Jun 10, 2024
0
35
The combination of bulevirtide plus peginterferon alfa-2a is superior to bulevirtide monotherapy for achieving undetectable hepatitis D virus (HDV) RNA level at 24 weeks after the end of treatment in patients with chronic ...
Jun 10, 2024
0
0
